Comparing the current results to its competitors, Medpace Holdings Inc reported Revenue increase in the 2 quarter 2026 by 17.24 % year on year. The sales growth was above Medpace Holdings Inc 's competitors' average revenue growth of 9.72 %, achieved in the same quarter.
Medpace Holdings Inc Net Income in the 2 quarter 2026 grew year on year by 34.46%, faster than the Medpace Holdings Inc 's competitors average income growth of 8.27 %
Medpace Holdings Inc 's Comment on Competition and Industry Peers
The company primarily competes with other full-service Contract Research Organizations (CROs) and the in-house research and development departments of biopharmaceutical companies. Key competitors include IQVIA Holdings Inc., ICON plc, PPD, Inc. (now part of Thermo Fisher Scientific Inc.), and Fortrea, Inc., along with various specialty and regional CROs. Competition factors encompass therapeutic area expertise, staff and service quality, reliability, service range, recruitment capability, global trial management, international presence, speed, pricing, and overall value. The CRO industry is fragmented, consisting of many smaller providers alongside a few full-service global companies. Significant barriers to entry exist for new global providers due to the high costs and experience required.
Overall company sales advanced by 17.24 % Medpace Holdings Inc outperformed its competitors in this segment and improved market share, to approx. 5.04 %. << More on MEDP Market Share.
*Market share is calculated based on total revenue.
Sotera Health operates a business model focused on providing sterilization services, packaging solutions, and consultancy services for medical device and pharmaceutical companies. They utilize a network of global facilities to ensure safe and effective sterilization processes for these products. By offering comprehensive solutions, Sotera Health aims to help its clients meet regulatory requirements and maintain product integrity.
Inotiv Inc is a contract research organization (CRO) that provides preclinical and nonclinical research services to the pharmaceutical, biotechnology, and medical device companies. The company offers a range of services including drug discovery, safety assessment, toxicology testing, and analytical services. By assisting clients with their research and development needs, Inotiv aims to contribute to the advancement of medicine and the development of new treatment options.
: { message: That model is currently overloaded with other requests. You can retry your request, or contact us through our help center at help.openai.com if the error persists. (Pleas
IQVIA Holdings Inc operates a multifaceted business model that focuses on delivering advanced analytics, technology solutions, and clinical research services tailored for the healthcare sector. By harnessing extensive data resources and industry expertise, the company aids clients in optimizing operations, enhancing drug development processes, and ultimately improving patient outcomes.
Sources:
Medpace Holdings Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Medpace Holdings Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
